The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review
I Mohammed, A Nauman, P Paul… - Human vaccines & …, 2022 - Taylor & Francis
With the relatively rapid development of the COVID-19 pandemic, vaccine development has
become crucial for limiting disease transmission. The accelerated growth in the approved …
become crucial for limiting disease transmission. The accelerated growth in the approved …
[HTML][HTML] COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
Abstracts Developing and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine
has garnered immense global interest. Less than a year after COVID-19 was declared a …
has garnered immense global interest. Less than a year after COVID-19 was declared a …
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England …
Objective To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and
Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including …
Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including …
[HTML][HTML] Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a …
EJ Haas, FJ Angulo, JM McLaughlin, E Anis, SR Singer… - The Lancet, 2021 - thelancet.com
Background Following the emergency use authorisation of the Pfizer–BioNTech mRNA
COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel …
COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel …
[HTML][HTML] Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Summary Background The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca
(ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase …
(ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase …
[HTML][HTML] Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
M Levine-Tiefenbrun, I Yelin, R Katz, E Herzel… - Nature medicine, 2021 - nature.com
Beyond their substantial protection of individual vaccinees, coronavirus disease 2019
(COVID-19) vaccines might reduce viral load in breakthrough infection and thereby further …
(COVID-19) vaccines might reduce viral load in breakthrough infection and thereby further …
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test …
H Chung, S He, S Nasreen, ME Sundaram, SA Buchan… - bmj, 2021 - bmj.com
Objective To estimate the effectiveness of mRNA covid-19 vaccines against symptomatic
infection and severe outcomes (hospital admission or death). Design Test negative design …
infection and severe outcomes (hospital admission or death). Design Test negative design …
BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting
Background As mass vaccination campaigns against coronavirus disease 2019 (Covid-19)
commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes …
commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes …
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
P Jalkanen, P Kolehmainen, HK Häkkinen… - Nature …, 2021 - nature.com
As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are
under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces …
under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces …
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
K Rahmani, R Shavaleh, M Forouhi… - Frontiers in public …, 2022 - frontiersin.org
Background Vaccination, one of the most important and effective ways of preventing
infectious diseases, has recently been used to control the COVID-19 pandemic. The present …
infectious diseases, has recently been used to control the COVID-19 pandemic. The present …